- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02920086
Improving Partnerships With Family Members of ICU Patients (IMPACT)
Improving Partnerships With Family Members of ICU Patients: The IMPACT Trial
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
There is a pressing need to improve the care of critically ill older patients. For critically ill patients who are frequently unable to participate in their own care and decision-making, partnering with their family members is particularly important for improving experiences and outcomes of care for both patients and families. However, the optimal means by which families engage in the role they play, and how best to capacitate them as advocates and partners in care while helping them maintain their own wellbeing, is not known.
The IMPACT trial will evaluate two interventions, each with a separate context, but similar in that they empower and support families; one focused on involvement in care, and the other focused on involvement in decision-making. The first is a nutrition intervention The OPTimal nutrition by Informing and Capacitating family members of best practices (OPTICs) intervention, a multi-faceted strategy to engage and empower family members to advocate for and audit best nutrition practices in their family members. The second is a decision support intervention. The REALISTIC-80 Decision Support Intervention, is a web-based tool (www.myicuguide.com) to support families in shared decision-making about goals of medical treatments.
The investigators propose to conduct a mixed methods multi-centre, open-label, randomized, clinical trial involving 3 groups (2 active interventions and a usual care group). The overall goal of this study is to demonstrate that the multi-faceted nutritional strategies that engage families in care of their family member tested in this trial will increase nutritional intake and optimize physical recovery in older critically ill patients at high nutrition risk.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Queensland
-
Gold Coast, Queensland, Australië
- Werving
- Gold Coast Health
-
Contact:
- Andrea Marshall
-
-
-
-
Alberta
-
Calgary, Alberta, Canada
- Ingetrokken
- University Of Calgary
-
-
Ontario
-
Ottawa, Ontario, Canada
- Werving
- University of Ottawa
-
Contact:
- Kwadwo Kyeremanteng
-
Toronto, Ontario, Canada
- Werving
- Sunnybrook Health Science Centre
-
Contact:
- Dominique Piquette
-
Toronto, Ontario, Canada
- Beëindigd
- University Health Network
-
-
-
-
Arizona
-
Phoenix, Arizona, Verenigde Staten, 85012
- Werving
- Phoenix VA Medical Center
-
Contact:
- Mary Chew
-
-
Missouri
-
Saint Louis, Missouri, Verenigde Staten, 63110-1093
- Werving
- Barnes Jewish Hospital/Washington University
-
Contact:
- Beth Taylor
-
-
Pennsylvania
-
Hershey, Pennsylvania, Verenigde Staten, 17033
- Werving
- Penn State Milton S. Hershey Medical Center
-
Contact:
- Lauren Van Scoy
-
-
Washington
-
Vancouver, Washington, Verenigde Staten, 98686
- Werving
- Legacy Salmon Creek Medical Center
-
Contact:
- Joseph Jura, Dr
-
-
Wisconsin
-
Milwaukee, Wisconsin, Verenigde Staten, 53226
- Werving
- Medical College of Wisconsin
-
Contact:
- Jayshil Patel
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria for Patients:
1a) > 60 years of age OR
1b) 55 years to 59 years old with one or more of the following diagnoses:
- Chronic obstructive lung disease - 2 of the 4 of: baseline PaCO2 of > 45 torr, cor pulmonale; respiratory failure episode within the preceding year; forced expiratory volume in 1 sec <0.5 L.
- Congestive heart failure - New York Heart Association class IV symptoms and left ventricular ejection fraction < 25%.
- Cirrhosis - confirmed by imaging studies or documentation of esophageal varices and one of three conditions: a) hepatic coma, b) Child's class C liver disease, or c) Child's class B liver disease with gastrointestinal bleeding.
- Cancer - metastatic cancer or stage IV lymphoma.
- End-stage dementia (inability to perform all ADLs, mutism or minimal verbal output secondary to dementia, bed-bound state prior to acute illness) 2) Have a projected duration of ICU dependency of >72 hours from time of final assessment. We define ICU dependency as the need for one or more of the following:
- Mechanical ventilation
- Non-invasive ventilation
- Renal replacement therapy
- Vasopressors or
- Artificial nutrition because of their underlying illness
Exclusion Criteria for Patients:
- Patients who are not expected to remain alive in ICU for 72 hours after initial screening (physician judgment) or for whom life-sustaining treatments are expected to be withdrawn in the subsequent 72 hours (as sufficient time will be required for implementation of the study interventions)
- Uncomplicated elective surgical patients (regardless of age)
- Patients who have received organ transplantation during this hospitalization
Inclusion Criteria for Family Member:
- 18 years of age or older,
- present and expected to visit regularly (minimum about 3 times a week) while the patient is in hospital
- the nominated or legally appointed substitute decision-maker
- able to communicate in English (verbally and in writing).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Nutrition Education Program
Nutrition education for family members of an elderly critically ill patient
|
Andere namen:
|
|
Experimenteel: Decision Support Program
Decision support education for family members of an elderly critically ill patient
|
Andere namen:
|
|
Geen tussenkomst: Gebruikelijke zorg
Geen tussenkomst
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Nutritional adequacy during the ICU stay
Tijdsspanne: Up to 30 days in ICU
|
Up to 30 days in ICU
|
|
|
Consumption of Oral Nutritional Supplements
Tijdsspanne: First four weeks once on ward
|
First four weeks once on ward
|
|
|
Intake on hospital wards (3 day calorie count)
Tijdsspanne: First four weeks once on ward
|
First four weeks once on ward
|
|
|
Hand grip strength
Tijdsspanne: At or before hospital discharge or up to 90 days
|
Hydraulic hand dynamometer
|
At or before hospital discharge or up to 90 days
|
|
Use of shared-decision making (OPTION tool)
Tijdsspanne: Within first week in ICU
|
Within first week in ICU
|
|
|
Change in decisional conflict
Tijdsspanne: 1 week
|
10-item Decisional Conflict Scale
|
1 week
|
|
Family satisfaction with decision-making
Tijdsspanne: 1 week
|
1 week
|
|
|
Overall family satisfaction with ICU
Tijdsspanne: At ICU discharge, an average of 12 days
|
At ICU discharge, an average of 12 days
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Daren Heyland, MD, Clinical Evaluation Research Unit
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IMPACT
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .